Executive summary Liver diseases have become a major health threat across Europe, and
the face of European hepatology is changing due to the cure of viral hepatitis C and the …

Drug-induced liver injury (DILI) is an adverse reaction to drugs or other xenobiotics that
occurs either as a predictable event when an individual is exposed to toxic doses of some …

Background & Aims Recent data on the coronavirus disease 2019 (COVID-19) outbreak
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has begun …

Background The clinical characteristics of novel coronavirus disease (COVID‐2019) patients
outside the epicenter of Hubei Province are less understood. Methods We analyzed the …

Cirrhosis–the common end-stage of chronic liver disease–is associated with a cascade of
events, of which intestinal bacterial overgrowth and dysbiosis are central. Bacterial toxins …

Recent advances in systemic and locoregional treatments for patients with unresectable or
advanced hepatocellular carcinoma (HCC) have resulted in improved response rates. This …

Superoxide dismutases (SODs) are metalloenzymes that play a major role in antioxidant
defense against oxidative stress in the body. SOD supplementation may therefore trigger the …

Drug-induced liver injury (DILI) can mimic almost all other liver disorders. A phenotype
increasingly ascribed to drugs is autoimmune-like hepatitis (ALH). This article summarises …

(1) Background: Drug repositioning is an unconventional drug discovery approach to
explore new therapeutic benefits of existing drugs. Currently, it emerges as a rapid avenue …

Idiosyncratic drug-induced liver injury mimics acute and chronic liver disease. It is under
recognized and underrecognised because of the lack of pathognomonic diagnostic …